Development of next generation BRAF protein kinase inhibitors: Rational design, green synthesis and biological evaluation on B-Raf inhibition and signalling in melanoma

Accessibility Controls

Principal Investigator

Dr. Ramars Amanchy

Scientist, Indian Institute of Chemical Technology (IICT), Hyderabad, Telangana

Area of Research

Pharmaceutical Sciences

Focus Area

BRAF protein kinase inhibitors

Start Date

2017

Sanction Amount

₹ 64.06 L

Contact

ramars@iict.res.in

No. of Research Paper

Technologies (If Any)

No. of PhD Produced

Publications

No. of Patents

Filed : 00

Grant : 00

Accessibility Controls